To the editors of the Pan African Medical Journal {#sec1}
=================================================

On the 15^th^ September 2017, Cochrane Africa was launched at the Global Evidence Summit in Cape Town, South Africa \[[@cit0001]\]. This network is the result of coordinated efforts to build capacity for conducting systematic reviews and promote the use of best evidence to inform healthcare decision making on the African continent.

This network is a much needed response to the high burden of disease, health system challenges and limited research capacity in sub-Saharan Africa \[[@cit0002], [@cit0003]\]. Beginning in 2007, African collaborators came together to encourage the production of high quality systematic reviews that are relevant to Africa and to support their use to inform policy and practice. We have since then, informed many national and international guidelines, especially in malaria, tuberculosis and HIV.

Cochrane Africa ([www.africa.cochrane.org](www.africa.cochrane.org)) includes a coordinating centre at Cochrane South Africa, a Francophone hub directed from Cameroon, a West Africa Hub directed from Nigeria and a Southern/Eastern Africa Hub directed from South Africa.

The Network\'s goal of increasing the use of best evidence to inform healthcare decision making in sub-Saharan Africa is accomplished through five activities: producing context-relevant systematic reviews identified through a consultative process with end-users based on their needs, priorities and acknowledged research gaps; building capacity to conduct and use systematic reviews; advocating for the dissemination, translation and use of evidence; building partnerships to promote African-led evidence-informed healthcare and creating opportunities for the network to grow.

Historically, there has only been one Cochrane Centre in Africa, Cochrane South Africa, with a branch in Nigeria. Cochrane Africa represents a unique opportunity to apply known methods for supporting evidence uptake to address issues that plague African health services including limited research capacity, high disease burden and limited use of evidence in formulating and implementing policy. It offers a platform for much needed South-South collaboration, sharing of experiences and addressing some barriers to evidence use in Africa \[[@cit0004]\]. Our work includes efforts to connect with Francophone and Lusophone countries to build capacity and support the production of systematic reviews in languages other than English. Our strengths lie in the breadth of the network, many years of experience, individual and institutional capacity strengthening and stakeholder engagement.

Conclusion {#sec2}
==========

We invite interested parties (researchers, health care providers, journalists, policy-makers, consumers) to visit our website and join us to strengthen the network, add relevance to the work we do and reduce inequities in health research that lead to inequities in health outcomes \[[@cit0005]\].
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